Skip to main content
FinSpry Logo
FinSpry
NUVB logo
NUVB
(NYSE)
Nuvation Bio Inc.
$6.49-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Nuvation Bio Inc. (NUVB) Analyst Forecast

Analyst consensus ratings, 12-month price targets, and expert recommendations for Nuvation Bio Inc. stock.

Analyst Consensus Rating

Investment consensus from 7 professional research analysts

Consensus Rating

Buy
Based on 7 unique analysts
(10 total ratings in last 90 days)
Medium Confidence∞:1 Buy/Sell

Average Price Target

$14.20
↑ 118.80% Upside

Loading chart...

Strong Sell
Sell
Hold
Buy
Strong Buy

Latest NUVB Analyst Ratings & Recommendations

Recent analyst recommendations with rating changes and price target updates (last 90 days)

Leonid Timashev
RBC Capital
BuyMaintains
$20.00 → $19.00
David Nierengarten
Wedbush
BuyMaintains
$11.00
Gregory Renza
Truist
BuyMaintains
-
Yaron Werber
TD Cowen
BuyReiterates
-
Robert Burns
HC Wainwright
BuyReiterates
$17.00
Mayank Mamtani
B Riley
BuyMaintains
$12.00
David Nierengarten
Wedbush
BuyMaintains
$11.00
Boris Peaker
JonesTrading
BuyMaintains
$10.00 → $12.00
Gregory Renza
Truist
BuyMaintains
$12.00
Leonid Timashev
RBC Capital
BuyMaintains
$20.00

Frequently Asked Questions

What is the analyst consensus rating for NUVB?

The analyst consensus rating for NUVB is "Buy" based on 7 analyst recommendations.

What is the average price target for NUVB?

The average 12-month price target for NUVB is $14.20, representing an upside of 118.8% from the current price of $6.49.

What do analyst ratings mean?

Analyst ratings indicate investment recommendations: Strong Buy and Buy are bullish signals suggesting the stock may outperform. Hold means the stock is fairly valued. Sell and Strong Sell are bearish signals suggesting potential underperformance. These ratings are based on fundamental analysis and valuation models.

What is a price target?

A price target is an analyst's projection of a stock's fair value over a specific timeframe, typically 12 months. Analysts use fundamental analysis, financial modeling, and industry comparisons to estimate where the stock should trade. Price targets can range from low (conservative) to high (optimistic) estimates.